Sector Chart RaQualia Pharma Inc.

Equities

Delayed Japan Exchange Other stock markets 11:30:00 29/05/2024 am IST			5-day change	1st Jan Change
535 ^JPY	-3.43%		-3.95%	-22.24%

26/03	RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	CI
14/02	RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes